OPKOPKO Health, Inc.
What is the market doing?
No clear lean: rangebound and moderately shorted.
Choppy, but holding above its 200-day average. Oversold (RSI 17). Price is +5% vs its 200-day average.
Moderately shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How OPK is trading
OPKO Health, Inc. is −4.8% over the past year while the S&P 500 is +18%: 23 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +4.7%
vs 200-day average · close to trend
- RSI (14)
- 17
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 20%
Below its 52-week high
Details›
- Last close2026-10-09
- $1.38
- 1 monthS&P 500 +2.7%
- −7.1%
- 1 yearS&P 500 +18%
- −4.8%
- 5 yearsS&P 500 +88%
- −60%
- vs 50-day average$1.51
- −8.6%
- 52-week high
- $1.73
- 52-week low
- $1.10
- Annualised volatility
- 46%
| Year | Return |
|---|---|
| 2026 (year to date) | +9.5% |
| 2025 | −14% |
| 2024 | −2.6% |
| 2023 | +21% |
| 2022 | −74% |
| 2021 | +22% |
| 2020 | +169% |
| 2019 | −51% |
| 2018 | −39% |
| 2017 | −47% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −1.8% |
| Feb | 10 | 2 of 10 | −7.5% |
| Mar | 10 | 4 of 10 | +2.4% |
| Apr | 10 | 3 of 10 | +0.89% |
| May | 10 | 5 of 10 | +2.3% |
| Jun | 10 | 7 of 10 | +15% |
| Jul | 11 | 5 of 11 | +4.1% |
| Aug | 11 | 4 of 11 | −3.2% |
| Sep | 11 | 6 of 11 | −1.1% |
| Oct | 11 | 3 of 11 | −8.6% |
| Nov | 10 | 7 of 10 | +4.4% |
| Dec | 10 | 2 of 10 | −6.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Diagnostics & Research
Ranks #19 of 21 by RyuScore